Breast Cancer Trial, Not Yet Recruiting NCT06934733 Sponsor: Henan Cancer Hospital Condition: Breast Cancer
Back to Breast Cancer

Breast Cancer Trial, Not Yet Recruiting

NCT06934733
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are willing to take part voluntarily, have signed a consent form, and are able to follow the study requirements.
  • People who are 18 years of age or older at the time of signing the consent form.
  • People who have locally advanced or returning/spreading breast cancer and who have not previously received a type of treatment called a TROP2-ADC (antibody-drug conjugate targeting TROP2).
  • People whose general physical health and ability to carry out daily activities falls within an acceptable range, as measured by a standard medical scale (ECOG score of 0–2).
  • People whose expected survival is greater than 3 months.
  • People whose blood, liver, kidney, and heart are functioning well enough to meet specific medical thresholds, and who have not received blood transfusions or certain blood-boosting treatments in the week before starting the study — specific requirements include:
    • Blood counts: sufficient levels of white blood cells, platelets, and haemoglobin.
    • Liver function: liver enzyme levels within acceptable limits (higher limits allowed if liver metastasis is present).
    • Kidney function: creatinine levels within acceptable limits, or kidney filtration rate at an adequate level.
    • Heart function: the heart's pumping ability is at least 50%, as measured by a heart scan.
  • People of reproductive potential who have a negative pregnancy test and who agree to use effective non-hormonal contraception during the study and for at least 3 months after the last dose.
  • People who agree to attend follow-up appointments as required by the study.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have previously received any treatment that targets TROP2.
  • People who currently have active mouth sores or ulcers inside the mouth.
  • People who have serious other health conditions that researchers believe could put them at risk or prevent them from completing the study — examples include uncontrolled high blood pressure, severe diabetes, or an active infection.
  • People whom the study doctor considers unsuitable for participation for any other reason.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 2 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Sponsor
Henan Cancer Hospital
Registry
ClinicalTrials.gov
Start date
1 May 2025
Est. completion
1 May 2027

Where this trial is recruiting

🇨🇳 China

Primary endpoints

The incidence and severity of oral mucositis within 8 weeks (scored according to the CECAE 5.0 standard)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov